These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Response to prednisone in relation to NR3C1 intron B polymorphisms in childhood nephrotic syndrome. Zalewski G; Wasilewska A; Zoch-Zwierz W; Chyczewski L Pediatr Nephrol; 2008 Jul; 23(7):1073-8. PubMed ID: 18343955 [TBL] [Abstract][Full Text] [Related]
23. [Study of morphological types of nephrotic glomerulonephritis and the number of glucocorticoid receptors of lymphocytes for prognosis of the effectiveness of glucocorticoid therapy]. Sasu BI; Mukhin NA; Serov VV; Varshavskiĭ VA Arkh Patol; 1984; 46(6):21-6. PubMed ID: 6383286 [TBL] [Abstract][Full Text] [Related]
24. In steroid sensitive nephrotic syndrome (SSNS) in children, is there clear evidence that steroids given every second day are more beneficial in terms of reducing relapse rate and side effects compared with half the dose given every day? Hodson EM; Craig JC Pediatr Nephrol; 2001 Dec; 16(12):1159-60. PubMed ID: 11793121 [No Abstract] [Full Text] [Related]
25. Alterations of glucocorticoid receptor expression during glucocorticoid hormone therapy in renal transplant patients. Berki T; Tavakoli A; Nagy KK; Nagy G; Németh P Transpl Int; 2002 Mar; 15(2-3):132-8. PubMed ID: 11935170 [TBL] [Abstract][Full Text] [Related]
26. [Interleukin-8 gene expression before and after the pulse treatment with methylprednisolone in primary nephrotic syndrome of children]. Luo G; Jiang H; Li W; Lü N Zhonghua Er Ke Za Zhi; 2003 Nov; 41(11):827-30. PubMed ID: 14728888 [TBL] [Abstract][Full Text] [Related]
27. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome]. Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389 [TBL] [Abstract][Full Text] [Related]
28. Comparison of the Safety of Prednisone Plus Dipyridamole Versus Prednisone Plus Valsartan in the Treatment of Children with Primary Nephrotic Syndrome. Chen G; Li W Iran J Kidney Dis; 2024 Aug; 18(4):204-211. PubMed ID: 39423092 [TBL] [Abstract][Full Text] [Related]
29. Long versus standard initial steroid therapy for children with the nephrotic syndromeA report from the Southwest Pediatric Nephrology Study Group. Lande MB; Gullion C; Hogg RJ; Gauthier B; Shah B; Leonard MB; Bonilla-Felix M; Nash M; Roy S; Strife CF; Arbus G Pediatr Nephrol; 2003 Apr; 18(4):342-6. PubMed ID: 12700959 [TBL] [Abstract][Full Text] [Related]
30. [Influence of glucocorticoid steroid therapy on gastric and duodenal mucosa and Helicobacter pylori infection in children with nephrotic syndrome]. Zajaczkowska M; Papierkowski A; Szczepanowska A; Zinkiewicz Z; Borzecka H; Zbarańska S Pol Merkur Lekarski; 2001 Mar; 10(57):165-7. PubMed ID: 11398518 [TBL] [Abstract][Full Text] [Related]
31. Cyclosporin A plus prednisone treatment of steroid-sensitive frequently relapsing nephrotic syndrome in children. Aksu N; Türker M; Erdoğan H; Ozinel S; Kansoy S Turk J Pediatr; 1999; 41(2):225-30. PubMed ID: 10770662 [TBL] [Abstract][Full Text] [Related]
32. Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome. Leonard MB; Feldman HI; Shults J; Zemel BS; Foster BJ; Stallings VA N Engl J Med; 2004 Aug; 351(9):868-75. PubMed ID: 15329424 [TBL] [Abstract][Full Text] [Related]
33. [Effect of glucocorticoid on glucocorticoid-resistant children with primary nephrotic syndrome]. He XJ; Yi ZW; Dang XQ; Zhang HQ; He QN; Mo SH; Bai HT; Geng WM; Yang HB Zhonghua Er Ke Za Zhi; 2005 Feb; 43(2):109-12. PubMed ID: 15833166 [TBL] [Abstract][Full Text] [Related]
34. [Multicenter study on present status of diagnosis and treatment of steroid-resistant nephrotic syndrome in children]. Subspecialty Group Of Nephrology, The Society Of Pediatrics Chinese Medical Association Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):483-7. PubMed ID: 25224050 [TBL] [Abstract][Full Text] [Related]
35. Prednisone dosing per body weight or body surface area in children with nephrotic syndrome: is it equivalent? Feber J; Al-Matrafi J; Farhadi E; Vaillancourt R; Wolfish N Pediatr Nephrol; 2009 May; 24(5):1027-31. PubMed ID: 19165504 [TBL] [Abstract][Full Text] [Related]
36. [Clinical effect of shenbing mistura combined with glucocorticoid on recurrent nephrotic syndrome in children and levels of interleukin-6 and tumor necrosis factor-alpha in blood and urine]. Hu GH; Dang XQ; Wang JH Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Oct; 26(10):892-5. PubMed ID: 17121039 [TBL] [Abstract][Full Text] [Related]
37. Childhood nephrotic syndrome in relapse is associated with down-regulation of monocyte CD14 expression and lipopolysaccharide-induced tumour necrosis factor-alpha production. Chen SP; Cheung W; Heng CK; Jordan SC; Yap HK Clin Exp Immunol; 2003 Oct; 134(1):111-9. PubMed ID: 12974763 [TBL] [Abstract][Full Text] [Related]
38. Increased maintenance corticosteroids during upper respiratory infection decrease the risk of relapse in nephrotic syndrome. Mattoo TK; Mahmoud MA Nephron; 2000 Aug; 85(4):343-5. PubMed ID: 10940745 [TBL] [Abstract][Full Text] [Related]
39. Combined therapy of low-dose tacrolimus and prednisone in nephrotic syndrome with slight mesangial proliferation. Miao L; Sun J; Yuan H; Jia Y; Xu Z Nephrology (Carlton); 2006 Oct; 11(5):449-54. PubMed ID: 17014560 [TBL] [Abstract][Full Text] [Related]
40. [Trial corticosteroid therapy on alternate days in children with nephrotic syndrome]. Lama G; Del Gado R Pediatria (Napoli); 1974 Dec; 82(4):569-75. PubMed ID: 4465757 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]